Web Results

en.wikipedia.org/wiki/Affymetrix

Affymetrix, Inc. was an American company that manufactured DNA microarrays; it was based in Santa Clara, California, United States. The company was acquired by Thermo Fisher Scientific in March 2016. The company was founded by Dr. Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, ...

en.wikipedia.org/wiki/Dionex

Dionex Corporation is an American company based in Sunnyvale, California. It develops, manufactures, sells, and services chromatography, ion chromatography and extraction systems for separating, isolating, and identifying the components of chemical mixtures. Such equipment is used in medical research, ...

www.perkinelmer.com/corporate/company/leadership/frank-witney.html

Biography of Frank Witney, Former Chief Executive Officer, Affymetrix, Inc.

www.crunchbase.com/person/frank-witney

Frank Witney brings more than 30 years of leadership and innovation in the research, development, and commercialization of many life science...

www.prnewswire.com/news-releases/frank-witney-joins-ampersand-as-operating-partner-300329292.html

Sep 19, 2016 ... WELLESLEY, Mass., Sept. 19, 2016 /PRNewswire/ -- Ampersand Capital Partners, a healthcare-focused, middle market private equity firm, is pleased to announce the addition of Frank Witney, PhD, as an Operating Partner. Dr. Witney is actively working with Ampersand's investment team to identify and ...

www.businesswire.com/news/home/20110601005817/en/Affymetrix-Appoints-Frank-Witney-Ph.D.-President-Chief

Jun 1, 2011 ... Affymetrix, Inc. (Nasdaq: AFFX) today announced that Dr. Frank Witney has been appointed president and chief executive officer, effective July 1, 2011.

cen.acs.org/articles/94/i35/CEN-Talks-Frank-Witney-executive.html

Sep 5, 2016 ... In 2009, Frank Witney became chief executive officer of the fast-growing ion chromatography expert Dionex. Two years later, he sold Dionex to Thermo Fisher Scientific for $2.1 billion. Witney then joined the struggling genetics microarray maker Affymetrix, where he helped engineer a turnaround. In March ...

ampersandcapital.com/portfolio-item/frank-r-witney

Sep 30, 2017 ... Frank R. Witney. Operating Partner. Frank, who joined Ampersand as an Operating Partner in 2016, serves as Chairman of Gyros Protein Technologies. Frank most recently served as CEO of Affymetrix, a leading provider of genomics and cell biology products that was sold in 2016 for $1.3 billion.

www.genomeweb.com/arrays/frank-witney-named-ceo-and-president-affymetrix-kevin-king-resigns

Jun 7, 2011 ... This story has been updated from a previous version to include Witney's salary details and the reactions of analysts and investors. By Justin Petrone. Frank Witney will replace Kevin King as CEO and president of Affymetrix, the firm announced last week. Witney's appointment is effective July 1, and he will ...